Chronic myeloid leukemia incidence, survival and accessibility of tyrosine kinase inhibitors: a report from population-based Lithuanian haematological disease registry 2000–2013

BACKGROUND: Currently available chronic myeloid leukaemia (CML) survival reports have originated from more affluent countries. Herein we report the entire country data on incidence and survival of CML, as well as penetrance of tyrosine kinase inhibitors (TKIs) in Lithuania. METHODS: We analyzed all...

Descripción completa

Detalles Bibliográficos
Autores principales: Beinortas, Tumas, Tavorienė, Ilma, Žvirblis, Tadas, Gerbutavičius, Rolandas, Jurgutis, Mindaugas, Griškevičius, Laimonas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4782571/
https://www.ncbi.nlm.nih.gov/pubmed/26956037
http://dx.doi.org/10.1186/s12885-016-2238-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4782571/
https://www.ncbi.nlm.nih.gov/pubmed/26956037
http://dx.doi.org/10.1186/s12885-016-2238-9

Ejemplares similares